Kennedy has criticized the popular Novo Nordisk (NYSE: NVO) drug Ozempic, which is often prescribed for weight loss, saying ...

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...

Novo Nordisk ( NVO -2.98%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

A series of health updates include WHO's funding for Uganda's Ebola response, CDC's isolation of a mpox patient in New York, ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Hims & Hers hit the bullseye with its Super Bowl ad—it sparked a lot of attention from consumers. | Hims & Hers hit the ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

Recent health news covers various topics: a new mpox case in New York, promising results of Ozempic for alcohol use disorder, U.S. impact on global health funding, Robert F. Kennedy Jr.'s health ...